Predictors of immune checkpoint inhibitor-related adverse events in older patients with lung cancer: a prospective real-world analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of immune checkpoint inhibitor-related adverse events in older patients with lung cancer: a prospective real-world analysis

Published:2023-05-10 Issue:11 Volume:149 Page:8993-9006
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Gao Jiayi,Zhang Ping,Tang Min,Nie Xin,Yuan Yue,Yang Fan,Li Lin

Funder

Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04792-1.pdf

Reference43 articles.

1. Agemi Y, Shimokawa T, Sasaki J, Miyazaki K, Misumi Y, Sato A, Aida S, Ishii M, Nakamura Y, Naoki K, Okamoto H (2019) Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: a single-institution study. PLoS ONE 14(1):e0210499. https://doi.org/10.1371/journal.pone.0210499

2. Atchley WT, Alvarez C, Saxena-Beem S, Schwartz TA, Ishizawar RC, Patel KP, Rivera MP (2021) Immune Checkpoint inhibitor-related pneumonitis in lung cancer: real-world incidence, risk factors, and management practices across Six Health Care Centers in North Carolina. Chest 160(2):731–742. https://doi.org/10.1016/j.chest.2021.02.032

3. Baldini C, Martin Romano P, Voisin AL, Danlos FX, Champiat S, Laghouati S, Kfoury M, Vincent H, Postel-Vinay S, Varga A, Vuagnat P, Ribrag V, Mezquita L, Besse B, Hollebecque A, Lambotte O, Michot JM, Soria JC, Massard C, Marabelle A (2020) Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapies. Eur J Cancer 129:71–79. https://doi.org/10.1016/j.ejca.2020.01.013

4. Baumjohann D, Brossart P (2021) T follicular helper cells: linking cancer immunotherapy and immune-related adverse events. J Immunother Cancer. https://doi.org/10.1136/jitc-2021-002588

5. Bellera CA, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M, Soubeyran PL (2012) Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 23(8):2166–2172. https://doi.org/10.1093/annonc/mdr587

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy;Human Vaccines & Immunotherapeutics;2024-09-13

2. Development and Validation of a Prediction Model for Thyroid Dysfunction in Patients During Immunotherapy;Endocrine Practice;2024-07

3. Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study;Drugs & Aging;2024-05

4. Clinical Features and Determinants of Disease Severity of Immune Checkpoint Inhibitor-Related Pneumonitis: A Retrospective Study;2024-04-03

5. The Progress of Research on the Roles of NLR, PLR, LMR, and Serum D-Dimer in Predicting the Efficacy of Immunotherapy for Lung Cancer;Advances in Clinical Medicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3